NIHR i4i & OLS Real World Evidence Programme
The NIHR Invention for Innovation (i4i) Programme, in collaboration with the Office for Life Sciences (OLS) and the National Institute for Health and Care Excellence (NICE), invites applications to the NIHR i4i & OLS Real World Evidence Programme.
The aim of the call is to support consortia to address real world evidence gaps to accelerate widespread adoption of technologies recommended for early use in the NHS through NICE Early Value Assessment (EVA). Funding will be deployed to generate real world evidence for product(s) to achieve a full NICE evaluation, generate further evidence required by commissioners to increase uptake, and to capture generalisable learnings to support future innovators. Applications that align with the Life Sciences Vision, published in July 2021, are particularly welcomed.
The NIHR i4i & OLS Real World Evidence Programme is a one-stage call inviting applications for projects up to 36 months in duration,with no upper funding limit.
The call will be open to consortia consisting of:
- An analytical partner (lead applicant) – which will lead and coordinate the generation of evidence required (must be a UK legal entity).
- The technology partner(s) – which will provide the EVA products for which evidence must be generated
- Adopting site(s) – which will give access to sites, or services, for testing of the products.
This call will be open to organisations which are UK legal entities, including large enterprises, small/medium commercial entities, NHS and social care providers, universities and research institutions, as well as not-for-profit organisations including charities and Community Interest Companies. For this call, the lead organisation should be the ‘analytical partner’ as described above.
Applications for funding close on 27th March 2024 13:00, if you would like to discuss this with someone in our team please message our Sector Lead, Aleksandra Love
To access the grant opportunity, submit your applications through the provided link, available here